209 related articles for article (PubMed ID: 33781566)
1. c-Kit expression in smooth muscle cells reduces atherosclerosis burden in hyperlipidemic mice.
Zigmond ZM; Song L; Martinez L; Lassance-Soares RM; Velazquez OC; Vazquez-Padron RI
Atherosclerosis; 2021 May; 324():133-140. PubMed ID: 33781566
[TBL] [Abstract][Full Text] [Related]
2. c-Kit suppresses atherosclerosis in hyperlipidemic mice.
Song L; Zigmond ZM; Martinez L; Lassance-Soares RM; Macias AE; Velazquez OC; Liu ZJ; Salama A; Webster KA; Vazquez-Padron RI
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H867-H876. PubMed ID: 31441677
[TBL] [Abstract][Full Text] [Related]
3. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
[TBL] [Abstract][Full Text] [Related]
4. Preventing Cholesterol-Induced Perk (Protein Kinase RNA-Like Endoplasmic Reticulum Kinase) Signaling in Smooth Muscle Cells Blocks Atherosclerotic Plaque Formation.
Chattopadhyay A; Guan P; Majumder S; Kaw K; Zhou Z; Zhang C; Prakash SK; Kaw A; Buja LM; Kwartler CS; Milewicz DM
Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):1005-1022. PubMed ID: 35708026
[TBL] [Abstract][Full Text] [Related]
5. USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.
Jean-Charles PY; Wu JH; Zhang L; Kaur S; Nepliouev I; Stiber JA; Brian L; Qi R; Wertman V; Shenoy SK; Freedman NJ
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2295-2305. PubMed ID: 30354204
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell-specific deletion of
Durgin BG; Cherepanova OA; Gomez D; Karaoli T; Alencar GF; Butcher JT; Zhou YQ; Bendeck MP; Isakson BE; Owens GK; Connelly JJ
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H943-H958. PubMed ID: 28283548
[TBL] [Abstract][Full Text] [Related]
7. Smooth Muscle Cell Notch2 Is Not Required for Atherosclerotic Plaque Formation in ApoE Null Mice.
Davis-Knowlton J; Turner JE; Harrington A; Liaw L
J Vasc Res; 2022; 59(5):261-274. PubMed ID: 35797968
[TBL] [Abstract][Full Text] [Related]
8. Smooth muscle α-actin missense variant promotes atherosclerosis through modulation of intracellular cholesterol in smooth muscle cells.
Kaw K; Chattopadhyay A; Guan P; Chen J; Majumder S; Duan XY; Ma S; Zhang C; Kwartler CS; Milewicz DM
Eur Heart J; 2023 Aug; 44(29):2713-2726. PubMed ID: 37377039
[TBL] [Abstract][Full Text] [Related]
9. Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation.
Wu JH; Zhang L; Nepliouev I; Brian L; Huang T; Snow KP; Schickling BM; Hauser ER; Miller FJ; Freedman NJ; Stiber JA
Cardiovasc Res; 2022 Feb; 118(3):772-784. PubMed ID: 33914863
[TBL] [Abstract][Full Text] [Related]
10. IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
Rattik S; Hultman K; Rauch U; Söderberg I; Sundius L; Ljungcrantz I; Hultgårdh-Nilsson A; Wigren M; Björkbacka H; Fredrikson GN; Nilsson J
Atherosclerosis; 2015 Oct; 242(2):506-14. PubMed ID: 26298743
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.
Shai SY; Sukhanov S; Higashi Y; Vaughn C; Kelly J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1916-24. PubMed ID: 20671230
[TBL] [Abstract][Full Text] [Related]
12. Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions.
Kim JB; Zhao Q; Nguyen T; Pjanic M; Cheng P; Wirka R; Travisano S; Nagao M; Kundu R; Quertermous T
Circulation; 2020 Aug; 142(6):575-590. PubMed ID: 32441123
[TBL] [Abstract][Full Text] [Related]
13. No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model.
Moss ME; DuPont JJ; Iyer SL; McGraw AP; Jaffe IZ
Front Cardiovasc Med; 2018; 5():81. PubMed ID: 30038907
[No Abstract] [Full Text] [Related]
14. Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human.
Pan H; Xue C; Auerbach BJ; Fan J; Bashore AC; Cui J; Yang DY; Trignano SB; Liu W; Shi J; Ihuegbu CO; Bush EC; Worley J; Vlahos L; Laise P; Solomon RA; Connolly ES; Califano A; Sims PA; Zhang H; Li M; Reilly MP
Circulation; 2020 Nov; 142(21):2060-2075. PubMed ID: 32962412
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
McGraw AP; Bagley J; Chen WS; Galayda C; Nickerson H; Armani A; Caprio M; Carmeliet P; Jaffe IZ
J Am Heart Assoc; 2013 Feb; 2(1):e000018. PubMed ID: 23525413
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
17. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.
Shankman LS; Gomez D; Cherepanova OA; Salmon M; Alencar GF; Haskins RM; Swiatlowska P; Newman AA; Greene ES; Straub AC; Isakson B; Randolph GJ; Owens GK
Nat Med; 2015 Jun; 21(6):628-37. PubMed ID: 25985364
[TBL] [Abstract][Full Text] [Related]
18. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-145 targeted therapy reduces atherosclerosis.
Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
[TBL] [Abstract][Full Text] [Related]
20. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
